Virtually Painless Frenuloplasty and Adult Circumcision – Offered by Gentle Procedures in Perth.

adult circumcision clinic perth

perth frenuloplasty doctor

cure for a tight penis banjo string

Gentle Procedures Perth is the only clinic in Western Australia to offer the virtually painless Pollock Technique™ circumcision for babies and men of all ages.

We have clients coming from all over Western Australia to access the adult circumcision and frenuloplasty care that our professional staff is pleased to offer at Gentle Procedures Perth”

— Dr. Newton

PERTH, WESTERN AUSTRALIA, AUSTRALIA, February 28, 2019 /EINPresswire.com/ — Gentle Procedures Perth is the first and only clinic in Western Australia to offer the virtually painless Pollock Technique™ circumcision for babies, boys and men of all ages.

The Pollock Technique™ provides for a relatively quick and pain-free circumcision procedure at the Perth location of Gentle Procedures Clinics. No hospital visit is necessary – even adult procedures are performed under local anesthetic with a short visit to the clinic for the procedure, as well as later follow up appointments.

Circumcisions can be performed for cultural or preference reasons, but also frequently for significant medical conditions such as phimosis. This is where the foreskin has become abnormally tight and scarred, causing pain, infections and hygiene problems.

Gentle Procedures Perth is also pleased to offer penile frenulectomy and frenuloplasty for WA men and teens.
Frenuloplasty (and frenulectomy) can offer long term relief from the pain of an overly tight penile frenulum. A short frenulum, or frenulum breve, can cause pain with erection and inhibit sexual relations. Often men suffer from frenulum breve without realizing that it is a treatable condition.

Frenulectomy is also performed as quick procedure, under local anaesthetic only, at the Gentle Procedures Clinic in Perth. Recovery is rapid.

"We have clients coming from all over Western Australia and beyond to access the adult circumcision and frenuloplasty care that our professional staff is pleased to offer to each patient at Gentle Procedures Perth," stated Dr. Richard Newton – clinic founder.

The circumcision and frenuloplasty procedures are done in under an hour at the Perth clinic location in Cottesloe. With the techniques employed, there is no need for patients to go to hospital, with all patients having the procedure done on an outpatient basis. Follow-up visits are scheduled for several days after the procedure.

"The Pollock circumcision method is a virtually pain-free technique that involves the use of a Mogen clamp along with long-acting local anesthetic and skin glue closure," continued Dr. Newton. "Our team will walk you through each step to ensure you fully understand what will happen and that you are prepared for the procedure."

Gentle Procedures is only one of very few circumcision providers in Australia that offers circumcision for all ages of infants, boys, adolescents, and men – as well as penile frenulectomy and frenuloplasty procedures.

Appointments are available quickly. Please contact the clinic directly to book a consultation, or for more information.

Dr Newton
Gentle Procedures Clinic
+61 8 9286 9900
email us here


Source: EIN Presswire

Spotlight on Branding Specialist and Serial Entrepreneur Fotis Georgiadis

Hospital GPS Smartphone App - Connexient

Hospital GPS Smartphone App – Connexient

Lawrence "LG" Greaves, CEO of OPKIX

Lawrence “LG” Greaves, CEO of OPKIX

Greg Shepard - Angel Investor/VC

Greg Shepard – Angel Investor/VC

A whirlwind tour of Fotis Georgiadis' work, interviews and interests.

The best moments in life are unplanned. We designed a camera to capture them – OPKIX ONE”

— OPKIX

GREENWICH, CT, USA, February 28, 2019 /EINPresswire.com/ — Fotis Georgiadis, owner of the blog by his namesake, is a branding and image consultant with a robust background and is a visionary interviewer.

Technology is shaping the future in ways that we didn't expect, even a few short years ago. With the advent of 5G, ubiquitous Wi-Fi, realistic virtual reality, artificial intelligence and more, the technological landscape has changed dramatically. Fotis Georgiadis has jumped on the high speed train to the future and interviewed a number of company representatives on the “Bleeding Edge” of technology. Thereby bringing this view of the future to the masses.

One such company recently interviewed by Fotis Georgiadis is Connexient. CEO Mark Green took some time to discuss 'indoor GPS' technologies. The interview is not just about the specific technology but brings out the person being interviewed. Hospitals are one area where indoor GPS systems can really help patients, doctors and visitors. Gone are the days of trying to find the name and location of a doctor or specific wing of a hospital by looking at the sign on the wall and trying to figure out where 'I am here' really is. Grab your smartphone, input your destination and the software will find the best route. As a result, people will no longer miss appointments because they can't find the correct office, thereby increasing efficiency and reducing costs.

“Was there a “tipping point” that led you to this breakthrough? Can you tell us that story?”

“The tipping point that led us to MediNav was realizing that people would come to expect the same type of mapping and navigation experience indoors, as they get outdoors. Using Google Maps or Waze while driving has become a way of life.”

This technology can be used for stadiums, race tracks, office complexes, cruise ships and more. Coming to an app store near you! Read all about Mark Green and Connexient here: https://tinyurl.com/yyfw72bt

Using a smartphone to capture life's moments can be fantastic but also challenging. Fotis Georgiadis took Lawrence “LG” Greaves, CEO of OPKIX, to the mat for some 1 on 1 discussions. Not only is OPKIX making “the world’s smallest, smartest, wearable cameras and video editing app”, they are also “looking to leverage the next phase of artificial intelligence to enhance the user experience of photo and video sharing” explained Lawrence “LG” Greaves, CEO of OPKIX. By interviewing the OPKIX CEO, Fotis Georgiadis is helping solidify their brand recognition, thereby increasing the reach of this new technology to a wider audience.

“All credit for the initial concept goes to my business partner, Shahin Armirpour. Shahin is an avid snowboarder. While snowboarding during 2016 in ultra low temperatures, his wearable camera not only died in the cold, but took forever to transfer video files…Not to mention, it wasn’t aesthetically designed, either.” commented Lawrence “LG” Greaves when asked about the tipping point that led to this wearable camera breakthrough.

Delve deeper into OPKIX and Lawrence “LG” Greaves by visiting http://www.fotisgeorgiadis.com

Fotis Georgiadis helps develop branding and awareness of both companies and individuals. A recent interview of Greg Shepard, a private angel investor/venture capitalist, not only furthered Greg's name/brand, but also brought to the forefront one of his current brand projects “a transit company looking to change the way people use public transportation. Subway, bus and metro rail riders across the country, both within big cities and in the surrounding areas, will attest to the frustrating inefficiency of the transit system.” Greg Shepard went on to explain how this company is changing the old magnetic strip technology to a chip that provides real time data to a cloud based system. As a result of better scheduling, location data, commuter congestion at a location and more, riders no longer are in the dark as to when the next bus or train will arrive.

“Things I Wish Someone Told Me Before I Started” – Greg Shepard

– Seek out mentors that fill your gaps
– Always take the high road
– Stay humble
– Surround yourself with honest people who carry similar values as you

Read the full interview over here: https://tinyurl.com/y66m626h

We can see by the above examples that Fotis Georgiadis is generating brand awareness for these companies and individuals in a more extensive way. The interviews serve as a mini biography of the individuals. Where they came from, how the project they are working on came about, what they see coming down the road. All of this information helps strengthen the 'imprint' of a brand across the web. In this digital age, there is no perfect way of getting word out about a company, a product or an individual. It becomes a combination of multiple avenues including, but not limited to, press releases, blog posts, social media, written/audio/video interviews and more, something Fotis Georgiadis specializes in. Head on over to his website for more articles and information.

About Fotis Georgiadis
Fotis Georgiadis is the founder of DigitalDayLab. Fotis Georgiadis is a serial entrepreneur with offices in both Malibu and New York City. He has expertise in marketing, branding and mergers & acquisitions. Fotis Georgiadis is also an accomplished VC who has successfully concluded five exits. Fotis Georgiadis is also a contributor to Authority Magazine, Thrive Global & several others

Contact

Fotis Georgiadis
Website: http://www.fotisgeorgiadis.com
Email: fg@fotisgeorgiadis.com
LinkedIn: https://www.linkedin.com/in/fotis-georgiadis-994833103/
Twitter: https://twitter.com/FotisGeorgiadi3 @FotisGeorgiadi3

Fotis Georgiadis
fotisgeorgiadis.com
+1 203-983-1234
email us here
Visit us on social media:
Twitter
LinkedIn

The OPKIX ONE Camera – Launch Video


Source: EIN Presswire

Blockbuster Drugs Market: Global Industry Analysis and Opportunity Assessment, 2019 – 2025

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025.

PUNE , MAHARASHTRA, INDIA, February 28, 2019 /EINPresswire.com/ — Global Blockbuster Drugs Industry

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025.

‘’Global Blockbuster Drugs Market 2015 – 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for global blockbuster drugs market. The report includes historic data from 2015 to 2017 and forecasts until 2025.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3602067-global-blockbuster-drugs-market-2015-2025-top-50

The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global blockbuster drugs market. The report explores detailed analysis of top 50 drugs market assessment globally from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the global research & development spend by pharma & biotech companies

Additionally, the report includes assessment of most valuable drugs research and development projects insights by phase and market value. Key trends in terms of collaboration, merger & acquisition, partnerships and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global blockbuster drugs market.

The report concludes with the profiles of major players in the global blockbuster drugs market. The key market players are evaluated on various parameters such as business overview and recent development.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

1) AbbVie
2) Celgene
3) Gilead Science
4) Merck
5) Roche
6) Bristol–Myers Squibb
7) Pfizer
8) Johnson & Johnson
9) Amgen
10) Biogen
11) Bayer
12) Regeneron Pharmaceuticals
13) Novo Nordisk
14) Allergan
15) Alexion Pharmaceuticals
16) GlaxoSmithKline
17) Novartis
18) Eli Lilly and Company
19) Astrazeneca
20) Incyte Corporation
21) Boehringer Ingelheim
22) Astellas Pharma

Top 50 Blockbuster Drugs Covered Under This Report Are:

1) Humira
2) Imbruvica
3) Revlimid
4) Genvoya
5) Truvada
6) Harvoni
7) Epclusa
8) Keytruda
9) Januvia/Janumet
10) Herceptin
11) Avastin
12) MabThera/Rituxan
13) Perjeta
14) Opdivo
15) Eliquis
16) Orencia
17) Sprycel
18) Lyrica
19) Ibrance
20) Simponi
21) Stelara
22) Zytiga
23) Invega Sustenna
24) Xarelto
25) Enbrel
26) Tagrisso
27) Tecfidera
28) Eylea
29) Victoza
30) Botox
31) Soliris
32) Triumeq
33) Seretide/Advair
34) Gilenya
35) Cosentyx
36) Trulicity
37) Cialis
38) Humalog
39) Symbicort
40) Zepatier
41) Pomalyst/Imnovid
42) Darzalex
43) Prolia/Xgeva
44) Ocrevus
45) Xtandi
46) Tivicay
47) Jakafi/Jakavi
48) Jardiance
49) Trajenta / Jentadueto
50) Relvar/Breo Ellipta

The Latest Industry Data Included in this Report:

Global Top 50 Blockbuster Drugs Market Size & Analysis (2015 – 2025)
Global Top 50 Blockbuster Drugs Market Share & Y–o–Y Growth (%), 2015 – 2025
Global Top 50 Blockbuster Drugs Market Assessment & Opportunity, (2015 – 2025)
Most Valuable Drugs Research and Development (R&D) Projects Insights by Phase and Market Value
Global Research & Development (R&D) Spend by Pharma & Biotech Companies (2015 – 2025)
Major Deals (Mergers, Acquisitions, Key Agreements, Partnerships & Collaborations)
Key Market Drivers and Inhibitors of the Global Blockbuster Drugs Market
Major Companies Analysis

The Answers to the Following Key Questions can be found in the Report:

What is the size of the global top 50 blockbuster drugs market during 2015 -2025?
What will be the revenue generated by each drug during the forecast period?
Which major drugs provides highest market share?
How are the overall market and major drugs growing?
What are the key drivers and inhibitors in the current market?
What will be the impact of drivers and inhibitors in the future?
How is the market predicted to develop in the future?
Who are the key players in this market space?

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3602067-global-blockbuster-drugs-market-2015-2025-top-50

Some Major Points from Table of content:

Executive Summary
Global Top 50 Blockbuster Drugs Market Size& Analysis (2015 – 2025)
Global Top 50 Blockbuster Drugs Market Share & Y–o–Y Growth (%), 2015 – 2025
Key Drivers and Inhibitors of the Global Blockbuster Drugs Market
4.1 Market Drivers
4.2 Market Inhibitors
Global Top 50 Blockbuster Drugs Market Assessment & Opportunity, (2015 – 2025)
5.1 Humira (Adalimumab)
5.2 Imbruvica (Ibrutinib)
5.3 Revlimid (Lenalidomide)
5.4 Pomalyst/Imnovid (Pomalidomide)
5.5 Genvoya (Cobicistat; Elvitegravir; Emtricitabine; Tenofovir Alafenamide fumarate)
5.6 Truvada (Emtricitabine / Tenofovir)
5.7 Harvoni (Ledipasvir / Sofosbuvir)
5.8 Epclusa (Sofosbuvir / Velpatasvir)
5.9 Keytruda (Pembrolizumab)
5.10 Januvia/Janumet (Sitagliptin / Metformin)
5.11 Herceptin (Trastuzumab)
5.12 Avastin (Bevacizumab)
5.13 MabThera/Rituxan (Rituximab)
5.14 Perjeta (Pertuzumab)
5.15 Opdivo (Nivolumab)
5.16 Eliquis (Apixaban)
5.17 Orencia (Abatacept)
5.18 Sprycel (Dasatinib)
5.19 Lyrica (Pregabalin)
5.20 Ibrance (Palbociclib)
5.21 Simponi (Golimumab)
5.22 Stelara (Ustekinumab)
5.23 Zytiga (Abiraterone acetate)
5.24 Invega Sustenna (Paliperidone)
5.25 Xarelto (Rivaroxaban)
5.26 Tagrisso (Osimertinib)
5.27 Enbrel (Etanercept)
5.28 Eylea (Aflibercept)
5.29 Victoza (Liraglutide)
5.30 Botox (Botulinum toxin)
5.31 Soliris (Eculizumab)
5.32 Triumeq (Abacavir / Dolutegravir / Lamivudine)
5.33 Seretide/Advair (Fluticasone propionate / Salmeterol)
5.34 Gilenya (Fingolimod)
5.35 Cosentyx (Secukinumab)
5.36 Trulicity (Dulaglutide)
5.37 Humalog (Insulin Lispro)
5.38 Cialis (Tadalafil)
5.39 Symbicort (Budesonide / Formoterol)
5.40 Zapatier (Elbasvir / Grazoprevir)
5.41 Tecfidera (Dimethyl fumarate)
5.42 Darzalex (Daratumumab)
5.43 Prolia/Xgeva (Denosumab)
5.44 Ocrevus (Ocrelizumab)
5.45 Xtandi (Enzalutamide)
5.46 Tivicay (Dolutegravir)
5.47 Jakafi/Jakavi (Ruxolitinib Phosphate)
5.48 Jardiance (Empagliflozin)
5.49 Trajenta/Jentadueto (Linagliptin)
5.50 Relvar/Breo Ellipta (Fluticasone furoate / Vilanterol)
Most Valuable Drugs Research and Development (R&D) Projects Insights by Phase and Market Value
Global Research & Development (R&D) Spend by Pharma & Biotech Companies (2015 – 2025)
Major Deals (Mergers, Acquisitions, Key Agreements, Partnerships & Collaborations)

Continued….

For more information or any query mail at sales@wiseguyreports.com

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Non-Invasive Prenatal Testing Market: Analysis and Industry Opportunity Assessment, 2019 – 2025

Global NIPT market is anticipated to grow over US$ 2.5 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.

PUNE , MAHARASHTRA, INDIA, February 28, 2019 /EINPresswire.com/ — Global Non-Invasive Prenatal Testing Industry

New Study on “2018-2025 Non-Invasive Prenatal Testing Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Global Non-Invasive Prenatal Testing(NIPT) market is anticipated to grow over US$ 2.5 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.

The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non-invasive techniques over invasive methods.

“Global Non-Invasive Prenatal Testing Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025” presents an in-depth assessment of the Global Non-Invasive Prenatal Testing (NIPT) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for Global Non-Invasive Prenatal Testing (NIPT). The research includes historic data from 2014 to 2017 and forecasts until 2025.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3206822-global-non-invasive-prenatal-testing-market-demand-insights

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of NIPT tests and Countries-based market. The report also includes assessment of comparative test analysis by companies. Additionally, the report includes insights into the Global perspectives on clinical adoption of NIPT. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Non-Invasive Prenatal Testing (NIPT) market.

The report concludes with the profiles of major players in the Global Non-Invasive Prenatal Testing (NIPT) market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolios and latest development and trends of the Non-Invasive Prenatal Testing (NIPT) market.

Key Findings:

United States is anticipated to be the most attractive market in the Global Non-Invasive Prenatal Testing(NIPT) market
• China NIPT test market is set to cross USD 400 Million by 2025
• Panorama test accounted for the highest share in Global Non-Invasive Prenatal Testing(NIPT) market
• Verifi test has the second highest revenue share in the Global Non-Invasive Prenatal Testing(NIPT) market
• Rising focus on Reimbursement for NIPT test will revolutionize the market
• Two–Child policy is likely to boost China NIPT market
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Illumina, Natera, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche), BGI Diagnosis Co. Ltd, Berry Genomics, Quest Diagnostics, LifeCodexx AG, Premaitha Health, NIPD Genetics

Major and Promising Non-Invasive Prenatal Testing (NIPT) Covered Under This Report are:

Panorama, MaterniT21 PLUS, Harmony, Verifi, NIFTY, IONA, PrenaTest, Bambni, Veracity and Other Tests

Major Countries Analyzed Under This Report are:

United States, China, Japan, India, Brazil, Australia, New Zealand, United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark and Rest of the Countries.

The Latest Industry Data Included in this Report:

Global Non–Invasive Prenatal Testing Market Volume & Future Trends (2014 – 2025)
• Global Non–Invasive Prenatal Testing Market Revenue & Future Trends (2014 – 2025)
• Global Non–Invasive Prenatal Testing Market Share and Y–o–Y Growth (%)
• Market Share Analysis, by Test, 2014 – 2025 (%)
• Market Share Analysis, by Major Countries, 2014 – 2025 (%)
• Global Non–Invasive Prenatal Testing Market, By Test (Volume and Value),2011 – 2025
• Global Non–Invasive Prenatal Testing Market, By Geography (Volume and Value),2014 – 2025
• Non–Invasive Prenatal Testing(NIPT) Comparative Analysis – By Test
• Major Deals in Global Non–Invasive Prenatal Testing Market
• Global Perspectives on Clinical Adoption of NIPT
• Global Non–Invasive Prenatal Testing Market Drivers and Inhibitors
• Key Companies Analysis
Some points from table of content:

REPORT SUMMARY
1. Executive Summary
2. Market Size & Analysis: Global Non–Invasive Prenatal Testing (Volume & Value),2014 – 2025
2.1.1 Global Non–Invasive Prenatal Testing Market Volume & Forecast
2.1.2 Global Non–Invasive Prenatal Testing Market Revenue & Forecast
3. Global Non–Invasive Prenatal Testing Market Share and Y–o–Y Growth (%)
3.1 Market Share Analysis, by Test, 2014 – 2025 (%)
3.1.1 Global Non-Invasive Prenatal Testing Market Volume Share, by Test, 2014 – 2025
3.1.2 Global Non-Invasive Prenatal Testing Market Revenue Share, by Test, 2014 – 2025
3.2 Market Share Analysis, by Major Countries, 2014 – 2025 (%)
3.2.1 Global Non-Invasive Prenatal Testing Market Volume Share, by Major Countries, 2014 – 2025
3.2.2 Global Non-Invasive Prenatal Testing Market Revenue Share, by Major Countries, 2014 – 2025
4. Non–Invasive Prenatal Testing(NIPT) Comparative Analysis – By Test
5. Global Non–Invasive Prenatal Testing Market Drivers and Inhibitors
5.1 Market Drivers
5.2 Market Inhibitors

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3206822-global-non-invasive-prenatal-testing-market-demand-insights

6. Global Non–Invasive Prenatal Testing Market, By Test (Volume and Value),2011 – 2025
6.1 Panorama Test
6.1.1 Panorama Test Volume (Number of Tests Performed) & Forecast
6.1.2 Panorama Test Market Revenue & Forecast
6.2 MaterniT21 Plus Test
6.2.1 MaterniT21 Plus Test Volume (Number of Tests Performed) & Forecast
6.2.2 MaterniT21 Plus Test Market Revenue & Forecast
6.3 Harmony Test
6.3.1 Harmony Test Volume (Number of Tests Performed) & Forecast
6.3.2 Harmony Test Market Revenue & Forecast
6.4 NIFTY Test
6.4.1 NIFTY Test Volume (Number of Tests Performed) & Forecast
6.4.2 NIFTY Test Market Revenue & Forecast
6.5 Verifi Test
6.5.1 Verifi Test Volume (Number of Tests Performed) & Forecast
6.5.2 Verifi Prenatal Test Market Revenue & Forecast
6.6 IONA Test
6.6.1 IONA Test Volume (Number of Tests Performed) & Forecast
6.6.2 IONA Test Market Revenue & Forecast
6.7 Prena Test
6.7.1 Prena Test Volume (Number of Tests Performed) & Forecast
6.7.2 Prena Test Market Revenue & Forecast
6.8 Bambni Test
6.8.1 Bambni Test Volume (Number of Tests Performed) & Forecast
6.8.2 Bambni Test Market Revenue & Forecast

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
841-198-5042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Diabetes Insulin Delivery Pens Market: Global Industry Analysis and Opportunity Assessment, 2019 – 2025

Diabetes Insulin Delivery Pen market will surpass US$ 14.4 Billion by 2025

PUNE , MAHARASHTRA, INDIA, February 28, 2019 /EINPresswire.com/ — Global Diabetes Insulin Delivery Pens Industry

New Study On “2018-2025 Diabetes Insulin Delivery Pens Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

Diabetes Insulin Delivery Pen market will surpass US$ 14.4 Billion by 2025.

Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices

“Diabetes Insulin Delivery Pens Market Research Report 2018”presents an in-depth assessment of the diabetes insulin delivery pen market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for diabetes insulin delivery pen market. The report includes historic data from 2011 to 2017 and forecasts until 2025.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3408696-diabetes-insulin-delivery-pens-market-research-report-2018

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, insulin pen volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025.It also provides an all-round analysis of overall number of patients with diabetes and insulin users. A comprehensive analysis has been done on market share of diabetes insulin delivery pen segment and countries-based market.The report also explores detailed description of growth drivers and inhibitors of the diabetes insulin delivery pens market.

The superior geographic segments are identified in the report, which also studies the prospects showcased by the emerging markets. It covers United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India and Brazil from 2011 to 2017 and forecasts to 2025.

The report concludes with the profiles of major players in the diabetes insulin delivery pens market. The key market players are evaluated on various parameters such as company overview, product portfolios and recent development of the diabetes insulin delivery pens market.

Market segment by Type, the product can be split into

Reusable Insulin Pens
• Disposable Insulin Pens
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd.

Major Countries Analyzed Under This Report are:

United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India and Brazil

The Latest Industry Data Included in this Report:

Diabetes Population in 10 major markets(10MM) 2011-2025
• Insulin Users Insights in 10 major markets(10MM) 2011 – 2025
• Total Diabetes Insulin Delivery Pen Users (Volume),2011 – 2025
• Reusable (Cartridge) Insulin Delivery Pen Users (Volume),2011 – 2025
• Prefilled (Disposable) Insulin Delivery Pen Users (Volume),2011 – 2025
• Total Diabetes Insulin Delivery Pen Market Size & Analysis (Value)2011-2025
• Reusable (Cartridge) Insulin Delivery Pen Market (Value),2011-2025
• Prefilled (Disposable) Insulin Delivery Pen Market (Value),2011-2025
• Total Diabetes Insulin Delivery Pen Market Share, By Users (%),2011 – 2025
• Reusable (Cartridge) Insulin Delivery Pen Market Share, By Users (%)2011 – 2025
• Prefilled (Disposable) Insulin Delivery Pen Market Share, By Users (%), 2011 – 2025
• Total Diabetes Insulin Delivery Pen Market Share (%),2011 – 2025
• Reusable (Cartridge) Insulin Delivery Pen Market Share (%),2011 – 2025
• Prefilled (Disposable) Insulin Delivery Pen Market Share (%),2011 – 2025
• Diabetes Insulin Delivery Pen Market, By Geography (Volume and Value),2011 – 2025
• Market Definition for the Specified Topic Along with Identification of Key Drivers
and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
Product Portfolios and Recent Development
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3408696-diabetes-insulin-delivery-pens-market-research-report-2018

Some Major Points from Table of content:

Executive Summary
Diabetes Insulin Delivery Pen Users (Volume),2011 – 2025
2.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users (Volume),2011 – 2025
2.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users (Volume),2011 – 2025

Diabetes Insulin Delivery Pen Market Size & Analysis (Value)2011-2025
3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market (Value),2011-2025
3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market (Value),2011-2025
Diabetes Insulin Delivery Pen Market Share, By Users (%),2011 – 2025
4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market Share, By Users (%)2011 – 2025
4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market Share, By Users (%), 2011 – 2025
Diabetes Insulin Delivery Pen Market Share (%),2011 – 2025
5.1 DiabtesReusable (Cartridge) Insulin Delivery Pen Market Share (%),2011 – 2025
5.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market Share (%),2011 – 2025
Key Market Drivers & Inhibitors of the Diabetes Insulin Delivery Pen Market
6.1 Market Drivers
6.2 Market Inhibitors
Diabetes Insulin Delivery Pen Market & Forecast (2011 – 2025) – Geographical Landscape
7.1 United States
7.1.1 Overall Diabetes Population & Forecast (Volume)
7.1.2 Insulin Users & Forecast (Volume)
7.1.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.1.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users(Volume)
7.1.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users (Volume)
7.1.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.1.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast(Value)
7.1.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
7.2 Germany
7.2.1 Overall Diabetes Population & Forecast (Volume)
7.2.2 Insulin Users & Forecast (Volume)
7.2.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.2.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users & Forecast (Volume)
7.2.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users & Forecast (Volume)
7.2.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.2.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast (Value)
7.2.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
7.3 France
7.3.1 Overall Diabetes Population & Forecast (Volume)
7.3.2 Insulin Users & Forecast (Volume)
7.3.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.3.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users & Forecast (Volume)
7.3.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users & Forecast (Volume)
7.3.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.3.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast (Value)

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
841-198-5042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Influenza Vaccines Market: United States Industry Analysis and Opportunity Assessment, 2019 – 2025

United States Influenza Vaccines market is set to touch US$ 3.5 Billion threshold by 2025.

PUNE , MAHARASHTRA, INDIA, February 28, 2019 /EINPresswire.com/ — United States Influenza Vaccines Industry

United States Influenza Vaccines market is set to touch US$ 3.5 Billion threshold by 2025.

“United States Influenza Vaccines Market Report, Analysis and Forecast to 2025” presents an in-depth assessment of the United States influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for United States influenza vaccines market. The report includes historic data from 2013 to 2017 and forecasts until 2025.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3471293-united-states-influenza-vaccines-market-report-analysis-and-forecast-to-2025

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the united states influenza vaccines market. The report also explores detailed analysis of number of children and adults vaccinated with influenza vaccines in United States from 2013 to 2017 and forecasts to 2025. The report also details the latest information about the influenza vaccines production, supply, and allocation by major companies in United States.

A comprehensive analysis has been done on pricing, distribution & demand and effectiveness of influenza vaccines in United States. It also provides a deep and thorough evaluation of distribution channel & technique of influenza vaccination. It covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States influenza vaccines market.

The report concludes with the profiles of major players in the United States influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development of influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi TanabePharma and Biondvax Pharmaceuticals Ltd, are making novel technology-based influenza vaccines which is likely to affect the market share during the forecast period.

The major companies dominating this market for its products, services and continuous product developments are:

Seqirus, Sanofi Pasteur, GlaxoSmithKline (GSK) and AstraZeneca

The Latest Industry Data Included in this Report:

United States Influenza Vaccines Market Size & Analysis (2013 – 2025)
• United States Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
• United States Number of Children Vaccinated with Influenza Vaccines (2013 – 2025)
• United States Number of Adults Vaccinated with Influenza Vaccines (2013 – 2025)
• United States Influenza Vaccines Pricing Trends & Analysis
• United States Influenza Vaccines Production, Supply, and Allocation (By Companies)
• United States Influenza Vaccines Distribution & Demand (2010 – 2018)
• Effectiveness of Influenza Vaccines in United States (2004 – 2018)
• Rapid Diagnostic Testing for the Management of Influenza
• Distribution Channel & Technique of Influenza Vaccination in United States
• United States Influenza Vaccines Reimbursement Policies & Regulatory System
• Major Deals in United States Influenza Vaccines Market
• Promising Influenza Vaccines in Clinical Development
• Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
• Market Definition for the Specified Topic Along with Identification of Key Driver and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
Vaccines Portfolios, Sales Value Analysis and Recent Development
Key questions answered in this research report:

At what pace is the influenza vaccines market growing in United States? What will be growth trend in future?
• How much number of persons being vaccinated with influenza vaccines during 2013 – 2025?
• What are the key drivers and inhibitors in the current market? What will be the impact of drivers and inhibitors in the future?
• What are the various influenza vaccines available in the United States?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3471293-united-states-influenza-vaccines-market-report-analysis-and-forecast-to-2025

Some Major Points from Table of content:

Executive Summary
United States Influenza Vaccines Market Size & Analysis (2013 – 2025)
United States Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
3.1 Number of Children Vaccinated with Influenza Vaccines
3.2 Number of Adults Vaccinated with Influenza Vaccines
Key Drivers and Inhibitors of the United States Influenza Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors
United States Influenza Vaccines Pricing Trends & Analysis
United States Influenza Vaccines Production, Supply, and Allocation (By Companies)
United States Influenza Vaccines Distribution & Demand (2010 – 2018)
Effectiveness of Influenza Vaccines in United States (2004 – 2018)
Rapid Diagnostic Testing for the Management of Influenza
Distribution Channel & Technique of Influenza Vaccination in United States
United States Influenza Vaccines Reimbursement Policies & Regulatory System
11.1 Reimbursement Policies
11.2 Regulation System
Major Deals in United States Influenza Vaccines Market
12.1 Merger & Acquisitions
12.2 Collaboration Deal
12.3 Licensing Agreement
12.4 Exclusive Agreement
12.5 Distribution Agreement
Continued…..

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
841-198-5042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Vaccines Market: United States Industry Analysis and Opportunity Assessment, 2019 – 2025

United States vaccines market is set to surpass US$ 21 Billion threshold by 2025.

PUNE , MAHARASHTRA, INDIA, February 28, 2019 /EINPresswire.com/ — United States Vaccines Industry

United States vaccines market is set to surpass US$ 21 Billion threshold by 2025.

“United States Vaccines Market 2015 – 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the United States vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for United States vaccines market. The report includes historic data from 2015 to 2017 and forecasts until 2025.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3548036-united-states-vaccines-market-2015-2025-top-21

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the United States vaccines market. The report also explores detailed analysis of top 21 vaccines market assessment in United States from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the vaccines pricing trends and regulatory landscape in United States.

Additionally, the report includes assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States vaccines market.

The report concludes with the profiles of major players in the United States vaccines market. The key market players are evaluated on various parameters such as business overview, promising vaccines in the clinical development and recent development.

The major companies dominating this market for its products, services and continuous product developments are:

Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline(GSK)

Top 21 Vaccines Covered Under This Report Are:

Prevnar/Prevnar 13
• Gardasil/Gardasil 9
• Fluzone
• Varivax
• Menactra
• Proquad
• Pneumovax
• FluLaval/Fluarix
• Havrix/Twinrix/Engerix-B
• MMR II
• Adacel
• Boostrix
• Bexsero
• Menveo
• Trumenba
• Shingrix
• Pentacel
• Recombivax HB
• Rotateq
• Rotarix
• Pediarix/Infanrix
The Latest Industry Data Included in this Report:

• United States Vaccines Market Size & Analysis (2015 – 2025)
• United States Vaccines Market Share & Y-o-Y Growth (%), 2015 – 2025
• United States Top 21 Vaccines Market Assessment & Opportunity (2015 – 2025)
• United States Vaccines Pricing Trends & Analysis
• United States Vaccines Regulatory System
• Major Deals in United States Vaccines Market
• Promising Vaccines in Clinical Development by Major Companies
• Key Market Drivers and Inhibitors of the United States Vaccines Market
• Major Companies Analysis

The answers to the following key questions can be found in the report:

What is the size of the United States vaccines market during 2015 -2025?
• What will be the revenue generated by each vaccine during the forecast period?
• Which major vaccine provides highest market share?
• How are the overall market and vaccine type growing?
• What are the key drivers and inhibitors in the current market? What will be the
impact of drivers and inhibitors in the future?
• What are the various vaccines available in the United States?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3548036-united-states-vaccines-market-2015-2025-top-21

Some Major Points from Table of content:

ExecutiveSummary
United States Vaccines Market Size & Analysis (2015 – 2025)
United States Vaccines Market Share & Y-o-Y Growth (%), 2015 – 2025
Key Drivers and Inhibitors of the United States Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors
United States Top 21 Vaccines Market Assessment & Opportunity (Value),2015 – 2025
5.1 Prevnar/Prevnar 13
5.2 Gardasil/Gardasil 9
5.3 Fluzone
5.4 Varivax
5.5 Menactra
5.6 Proquad
5.7 Pneumovax 23
5.8 Fluarix/FluLaval
5.9 Havrix/Twinrix/Engerix-B
5.10 M-M-R II
5.11 Adacel
5.12 Boostrix
5.13 Bexsero
5.14 Menveo
5.15 Trumenba
5.16 Shingrix
5.17 Pentacel
5.18 Recombivax HB
5.19 Rotateq
5.20 Rotarix
5.21 Pediarix/Infanrix
5.22 Other Vaccines
Continued….

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Introducing the first Aston Baker Cutting Edge Global Aesthetic Symposium Livestreamed from Colombia March 30-31, 2019.

NEW YORK CITY, NY, USA, February 28, 2019 /EINPresswire.com/ — Dr. Sherrell J. Aston and Dr. Daniel C. Baker are proud to announce the first Aston Baker Cutting Edge Global Aesthetic Symposium, "It's Just Surgery – Advanced Body Sculpting", which will premier this March 30 -31, 2019 from Bogota Colombia. The program has been designed for high impact learning by direct visualization of live surgery via live stream technology on the internet.

This symposium is based on the same high-level educational experience and state of the art plastic surgery innovation you have come to expect over the years from The Aston Baker Cutting Edge meeting in New York City.

High level curated content by Dr. Aston and Dr. Baker and a mix of U.S. and International surgeons operating live from four operating rooms will be simultaneously live streamed around the world, directly to your phone, tablet or computer.

Why Live Stream?

• Speed – Fastest and most efficient method of information transfer is through real-time observation of surgical operative cases. All that is necessary is a High-Speed internet connection.

• Methodology – A LIVE explanation of steps, techniques and surgical reasoning, allows for an immediate and accurate transfer of information in the latest state of the art medium that has become the second-best option after hands-on practice.

• Education – Earn CME credits in the comfort of your home, office or on the go while learning the latest advancements in Cutting Edge Body Contouring.

• Expense – Travel expenses associated with visiting physical locations for a meeting are now obsolete. In addition to a loss of revenue and time away from the office, live streaming surgery constitutes the most efficient transfer of information in the shortest amount of time.

Dr. Aston and Dr. Baker will be serving as Course Chairmen and moderating the symposium in the same format as they do for the New York City meeting every year.

Colombian Plastic Surgeon, Alfredo E. Hoyos, MD, will be acting as Program Director. Dr. Hoyos is the creator of High Definition Liposculpture and other advanced body contouring techniques, as well as author of "High Definition Body Sculpting: Art and Advanced Lipoplasty Techniques".

Surgeons Alfredo E. Hoyos, MD, Daniel A. Del Vecchio, MD, Constantino G. Mendieta, MD, Spero J. Theodorou, MD and Christopher T. Chia, MD will be performing live surgeries.

Dr. Daniel A. Del Vecchio is an internationally acclaimed plastic surgeon and inventor of the EVL (Expansion Vibration Lipofilling) technique for buttock shaping and lifting.

Dr. Constantino G. Mendieta has an international reputation as a world-renowned buttock enhancement expert and the author of "The Art of Gluteal Sculpting".

Dr. Spero J. Theodorou is an international figure within the field of plastic surgery, and a widely acclaimed expert on emerging technologies in body contouring and inventor of the non-excisional arm lift.

Dr. Christopher T. Chia is a recognized plastic surgeon from his excellent research and publications in body contouring as well as the inventor of the Brazilian Butt Lift Under Local Anesthesia (BUBBLA).

Doctors from all over the globe will have access to the best training and the brightest minds in cosmetic surgery. Experts will show their cutting-edge techniques and procedures for all to see.

This event will provide an exclusive and exceptional educational experience for surgeons who want to take their practice to another level with the fastest and most efficient method of information transfer through real-time observation of surgical operative cases.

For program details and registration visit our website at www.astonbakerglobal.com.

For press inquiries please contact:

Bernadette McGoldrick
Aston Baker Cutting Edge Global Aesthetic Symposium
+1 212-327-4681
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

DR. ASTON INTRODUCING THE FIRST EVER ASTON BAKER CUTTING EDGE GLOBAL AESTHETIC SYMPOSIUM – COLOMBIA


Source: EIN Presswire

CerSci Therapeutics Announces FDA Notification that First Clinical Trial of Non-Opioid Analgesic for Pain May Proceed

DALLAS, TEXAS, USA, February 27, 2019 /EINPresswire.com/ — CerSci Therapeutics, a non-opioid drug development firm based in Dallas, Texas, announced today that their Investigational New Drug (IND) application for CT-044 has received notification from the United States Food and Drug Administration (FDA) indicating that its Phase I safety and tolerability clinical trial may proceed. CT-044, a non-metal based, orally bioavailable, small molecule Radical Species Decomposition Accelerant (RSDAx) of peroxynitrite and hydrogen peroxide, is proposed for the treatment of acute and chronic pain, including acute post-surgical pain and painful diabetic neuropathy.

“Notification that our first study in the clinic may proceed marks a tremendous milestone for CerSci Therapeutics,” said Co-Founder and Chief Executive Officer Dr. Lucas Rodriguez. The transition of CT-044 from pre-clinical development into the clinic offers hope for patients needing an alternative to opiates in the treatment of pain. The need to address the opioid crisis is becoming ever more urgent; approximately 130 Americans die each day from an opioid overdose. We at CerSci believe that our new, non-opioid based therapy will be a more reliable and responsible treatment for pain, which will benefit both patients and caregivers.”

CerSci’s Chief Scientific Officer, Dr. Scott Dax added, “CT-044 operates by targeting and rapidly removing peroxynitrite in a catalytic manner.” Dr. Dax continued, “CT-044 disrupts or prevents ensuing cascades initiated by peroxynitrite that lead to neuronal hypersensitivity thereby providing a long duration of pain relief. The CT-044 platform offers tremendous potential for the design and development new drugs to completely change the way in which we treat pain and neurodegenerative diseases.”

Preclinical development work on CT-044 has been supported by a Phase II Small Business Innovation Research (SBIR Grant from the National Institutes of Health, titled “Orally Bioavailable Peroxynitrite Decomposition Catalyst Targeting Post Surgical Pain”).

About CerSci Therapeutics
With a focus on alleviating human suffering and rescuing society from the ongoing opioid crisis, CerSci Therapeutics is poised to deliver a new generation of non-opioid medicines to treat acute postoperative and chronic neuropathic pain (painful diabetic neuropathy).

Lucas Rodriguez
CerSci Therapeutics
+1 2149020484
email us here


Source: EIN Presswire

Less than 3 weeks to SMi's 3rd Annual Drug Discovery Chemistry Conference

SMi Reports: The countdown begins to the highly anticipated Drug Discovery Chemistry conference in London.

LONDON, GREATER LONDON, UNITED KINGDOM, February 27, 2019 /EINPresswire.com/ — The drug discovery field is undergoing dramatic change with a new opportunity for the development of novel medicines and technologies within the pharmaceutical market.

In just 3 weeks, the Drug Discovery Chemistry conference will open its doors on the 18th and 19th March in London, creating a forum that will discuss the latest innovations in drug discovery chemistry, as well as strategies to deliver small molecules.

The two-day event features 18 thought-provoking presentations, and 4+ hours of networking that will discuss key themes surrounding this ever-changing field of science.

Industry experts will answer these key questions at Drug Discovery Chemistry 2019, including:

1. How arsenic methyl transferase is effective and the potential role in CNS?
AstraZeneca will be discussing the discovery of a form of arsenic methyl transferase (AS3MT).

2. What are the new approaches to drug (chemical biology) the undruggable?
Novartis presents their efforts in chemical biology, exploring new technologies, new modalities and how to win!

3. Are there any advantages of using artificial intelligence in early drug discovery?
Berg LLC, will be discussing the advances in how AI can be used to identify druggable targets and further delve in the opportunities of the drug discovery process.

4. What are the uses and advantages of macrocycles and synthesis for commercial use?
Cylenium Pharma discusses the benefits of macrocycles as an emerging part of chemical space and its potential to drug genomic targets.

5. How is machine learning in drug discovery important?
Bayer will present their findings on machine learning for ADME predications and determining the next steps in the drug discovery process

6. What are the important aspects of fragment-based library design – Ro3 and Beyond?
AbbVie will provide a case study of how the newly designed fragments enabled a fragment to lead campaign in short order.

7. How encoded library technology in nanospheres work?
Nanna Therapeutics will provide an insight into their proprietary screening and AI platform (T.I.M.E.) to speed-up drug discovery, and also provide highlights form their recent case studies.
Download the conference brochure with the full two-day agenda and speaker line up at http://www.drug-discovery.co.uk/pr5

The conference has attracted a global audience of experts raring to explore the latest scientific breakthroughs and highlight future opportunities for novel therapeutic discovery.
Register online for the conference and/or post-conference workshop at http://www.drug-discovery.co.uk/pr5.

Plus, you can register at the special manager’s rate of £999 expiring on Friday 1st March 2019.

Proudly sponsored by Selvita
For sponsorship opportunities please contact Alia Malick, Director on +44 (0) 20 7827 6168 or email amalick@smi-online.co.uk.

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Drug Discovery Chemistry
Conference: 18th & 19th March 2019
Copthorne Tara Hotel, London, UK
http://www.drug-discovery.co.uk/pr5

Follow us @SMiPharm on Twitter
#SMiDrugDischem

—- END —-
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
+1 2078276000
email us here


Source: EIN Presswire